These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8571332)

  • 1. Aurintricarboxylic acid reduces platelet deposition in stenosed and endothelially injured rabbit carotid arteries more effectively than other antiplatelet interventions.
    Golino P; Ragni M; Cirillo P; Pascucci I; Ezekowitz MD; Pawashe A; Scognamiglio A; Pace L; Guarino A; Chiariello M
    Thromb Haemost; 1995 Sep; 74(3):974-9. PubMed ID: 8571332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antithrombotic effect of aurin tricarboxylic acid in the guinea pig is not solely due to its interaction with the von Willebrand factor-GPIb axis.
    Azzam K; Cissé-Thiam M; Drouet L
    Thromb Haemost; 1996 Jan; 75(1):203-10. PubMed ID: 8713802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-glycoprotein Ib causes platelet aggregation: different effects of blocking glycoprotein Ib and glycoprotein IIb/IIIa in the high shear filterometer.
    O'Brien JR; Etherington MD
    Blood Coagul Fibrinolysis; 1998 Sep; 9(6):453-61. PubMed ID: 9818994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis].
    Ragni M; Golino P; Cirillo P; Pascucci I; Scognamiglio A; Ravera A; Esposito N; Battaglia C; Guarino A; Chiariello M
    Cardiologia; 1996 Jan; 41(1):51-8. PubMed ID: 8697470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.
    Hoylaerts MF
    Verh K Acad Geneeskd Belg; 1997; 59(3):161-83. PubMed ID: 9490916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple inhibition of platelet activation by aurintricarboxylic acid prevents vascular stenosis after endothelial injury in hamster carotid artery.
    Matsuno H; Kozawa O; Niwa M; Tanabe K; Ichimaru K; Takiguchi Y; Yokota M; Hayashi H; Uematsu T
    Thromb Haemost; 1998 Apr; 79(4):865-71. PubMed ID: 9569206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High shear stress attenuates agonist-induced, glycoprotein IIb/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib/IX is blocked.
    Iijima K; Murata M; Nakamura K; Kitaguchi T; Handa M; Watanabe K; Fujimura Y; Yoshioka A; Ikeda Y
    Biochem Biophys Res Commun; 1997 Apr; 233(3):796-800. PubMed ID: 9168936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of leucocyte and platelet adhesion reduces neointimal hyperplasia after arterial injury.
    Golino P; Ambrosio G; Ragni M; Cirillo P; Esposito N; Willerson JT; Rothlein R; Petrucci L; Condorelli M; Chiariello M; Buja LM
    Thromb Haemost; 1997 Apr; 77(4):783-8. PubMed ID: 9134659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porcine von Willebrand factor binding to human platelet GPIb induces transmembrane calcium influx.
    Mazzucato M; De Marco L; Pradella P; Masotti A; Pareti FI
    Thromb Haemost; 1996 Apr; 75(4):655-60. PubMed ID: 8743195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
    Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
    Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epinephrine and shear stress synergistically induce platelet aggregation via a mechanism that partially bypasses VWF-GP IB interactions.
    Wagner CT; Kroll MH; Chow TW; Hellums JD; Schafer AI
    Biorheology; 1996; 33(3):209-29. PubMed ID: 8935180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of von Willebrand factor binding to platelet GP Ib by a fractionated aurintricarboxylic acid prevents restenosis after vascular injury in hamster carotid artery.
    Matsuno H; Kozawa O; Niwa M; Uematsu T
    Circulation; 1997 Aug; 96(4):1299-304. PubMed ID: 9286962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental carotid stenosis and endothelial injury in the rabbit: an in vivo model to study intravascular platelet aggregation.
    Golino P; Ambrosio G; Pascucci I; Ragni M; Russolillo E; Chiariello M
    Thromb Haemost; 1992 Mar; 67(3):302-5. PubMed ID: 1641819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions.
    Rivera J; Escolar G; Casamiquela R; Bravo MI; Jorquera JI; Castillo R; Ordinas A; Vicente V
    Haematologica; 1999 Jan; 84(1):5-11. PubMed ID: 10091386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperacute lung rejection in the pig-to-human model. III. Platelet receptor inhibitors synergistically modulate complement activation and lung injury.
    Pfeiffer S; Zorn GL; Zhang JP; Giorgio TD; Robson SC; Azimzadeh AM; Pierson RN
    Transplantation; 2003 Apr; 75(7):953-9. PubMed ID: 12698079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor.
    Cauwenberghs N; Schlammadinger A; Vauterin S; Cooper S; Descheemaeker G; Tornai I; Deckmyn H
    Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel monoclonal antibody against the extracellular domain of GPIbbeta modulates vWF mediated platelet adhesion.
    Perrault C; Moog S; Rubinstein E; Santer M; Baas MJ; de la Salle C; Ravanat C; Dambach J; Freund M; Santoso S; Cazenave JP; Lanza F
    Thromb Haemost; 2001 Nov; 86(5):1238-48. PubMed ID: 11816713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shear stress-induced binding of von Willebrand factor to platelets.
    Konstantopoulos K; Chow TW; Turner NA; Hellums JD; Moake JL
    Biorheology; 1997; 34(1):57-71. PubMed ID: 9176590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
    Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
    Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.